Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2025-12-25 @ 1:24 PM
NCT ID:
NCT00103259
Group ID:
EG001
Title:
Arm II (Bortezomib)
Description:
Patients receive bortezomib (PS-341) 1.3 mg/m2 IV over 3-5 seconds twice weekly on days 1, 4, 8 and 11 followed by one week of rest. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity. Upon disease progression, patients may cross over to arm I (bortezomib + irinotecan).
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
21
Serious Number At Risk:
41
Other Number Affected:
40
Other Number At Risk:
41
Study:
NCT00103259
Results Section:
NCT00103259
Adverse Events Module:
NCT00103259